The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury
Open accessAbstract
The integrity of the blood–brain barrier (BBB) is critical for normal brain function, and its compromise contributes to the pathophysiology of a number of CNS diseases and injuries. Using a rodent model of brain injury, the present study examines the pathophysiology of BBB disruption. Western blot and immunohistochemical analyses indicate that brain injury causes a loss of capillary endothelial cells and tight junction proteins, two critical components of the BBB. Activation of the transcription factor NF-E2-related factor-2 (Nrf2) by sulforaphane, a naturally occurring compound present in high levels in cruciferous vegetables, significantly increased the expression of endogenous cytoprotective genes in brain tissue and microvessels as indicated by real-time PCR analysis. Postinjury administration of sulforaphane reduced the loss of endothelial cell markers and tight junction proteins and preserved BBB function. These protective effects were dependent on the activity of Nrf2. Injured rats pretreated with decoy oligonucleotides containing the binding site of Nrf2, and mice lacking the nrf2 gene, did not benefit from sulforaphane administration. These findings indicate a potential therapeutic usefulness for Nrf2-activating molecules to improve the function of the neurovascular unit after injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 5×
“It has been reported that sulforaphane increases nuclear Nrf2 levels, possibly by suppressing Keap1-mediated proteosomal degradation (McMahon et al., 2003).”
BackgroundInfluentialZhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 2×
“Cellular stressors reduce the proteosomal degradation of Nrf2, resulting in its nuclear accumulation and increased expression of Nrf2-driven genes (Pi et al., 2003; Zhang and Hannink, 2003).”
BackgroundKeap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S.-C., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,254
(2002) · PubMed · Cited by 1,190
McMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141 · cited 2×
“It has been reported that sulforaphane increases nuclear Nrf2 levels, possibly by suppressing Keap1-mediated proteosomal degradation (McMahon et al., 2003).”
BackgroundA controlled cortical impact model of traumatic brain injury in the rat
Edward Dixon, C., Clifton, G. L., Lighthall, J. W., Yaghmai, A. A., & Hayes, R. L. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90104-8 · Cited by 1,141
Kobayashi, M., & Yamamoto, M. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.007 · Cited by 856
Lee, J.-M., Calkins, M. J., Chan, K., Kan, Y. W., & Johnson, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211558200 · Cited by 786
McMahon, M. J., Itoh, K., Yamamoto, M. P., Chanas, S. A., Henderson, C. J., McLellan, L. I., Wolf, C. R., Cavin, C., & Hayes, J. D. (2001) · PubMed · Cited by 651
Inflammatory Mechanisms after Ischemia and Stroke
Danton, G. H., & Dietrich, W. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.2.127 · Cited by 551
Kang, M.-I., Kobayashi, A., Wakabayashi, N., Kim, S.-G., & Yamamoto, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308347100 · Cited by 534
Fishman, R. A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510022931407 · Cited by 411
The Blood–Brain Barrier and Epilepsy
Oby, E., & Janigro, D. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00817.x · Cited by 388
Brain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals
Chan, P. H., Schmidley, J. W., Fishman, R. A., & Longar, S. M. (1984) · Neurology · doi:10.1212/wnl.34.3.315 · Cited by 382
The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
Zipper, L. M., & Mulcahy, R. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206530200 · Cited by 366 · cited 1×
“In addition to sequestering Nrf2, these oligonucleotides may also bind the related transcription factor Nrf1 (Itoh et al., 1999; Zipper and Mulcahy, 2002), making it difficult to specifically address a role for Nrf2.”
BackgroundJunctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
Petty, M. A., & Lo, E. H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00128-4 · Cited by 360
Başkaya, M. K., Muralikrishna Rao, A., Doğan, A., Donaldson, D., & Dempsey, R. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00239-5 · Cited by 332
HU, R., XU, C., SHEN, G., JAIN, M., KHOR, T., GOPALKRISHNAN, A., LIN, W., REDDY, B., CHAN, J., & KONG, A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.050 · Cited by 241
Activation of the Nrf2–ARE signaling pathway: a promising strategy in cancer prevention
Giudice, A., & Montella, M. (2006) · BioEssays · doi:10.1002/bies.20359 · Cited by 234
Pi, J., Qu, W., Reece, J. M., Kumagai, Y., & Waalkes, M. P. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00341-0 · Cited by 228
Hu, R., Hebbar, V., Kim, B.-R., Chen, C., Winnik, B., Buckley, B., Soteropoulos, P., Tolias, P., Hart, R. P., & Kong, A.-N. T. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064261 · Cited by 219
Gao, X., Dinkova-Kostova, A. T., & Talalay, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261572998 · Cited by 199
DeWitt, D. S., & Prough, D. S. (2003) · Journal of Neurotrauma · doi:10.1089/089771503322385755 · Cited by 195 · cited 1×
“BBB compromise contributes to the pathological changes associated with a number of neurological diseases, brain tumors, and CNS injury (Petty and Lo, 2002; DeWitt and Prough, 2003; Oby and Janigro, 2006).”
BackgroundSMITH, S. L., ANDRUS, P. K., ZHANG, J.-R., & HALL, E. D. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.393 · Cited by 194
Masliah, E., Ellisman, M., Carragher, B., Mallory, M., Young, S., Hansen, L., Deteresa, R., & Terry, R. D. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199207000-00003 · Cited by 183
Mikawa, S., Kinouchi, H., Kamii, H., Gobbel, G. T., Chen, S. F., Carlson, E., Epstein, C. J., & Chan, P. H. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.85.5.0885 · Cited by 169
Shapira, Y., Setton, D., Artru, A. A., & Shohami, E. (1993) · Anesthesia & Analgesia · doi:10.1213/00000539-199307000-00028 · Cited by 156
Shohami, E., Novikov, M., & Mechoulam, R. (1993) · Journal of Neurotrauma · doi:10.1089/neu.1993.10.109 · Cited by 133
Dash, P. K., Moore, A., & Dixon, C. E. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02030.1995 · Cited by 106
Self-citationRegulation of Nrf2, NF-κB, and AP-1 Signaling Pathways by Chemopreventive Agents
Shen, G., Jeong, W., Hu, R., & Kong, A. T. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1648 · Cited by 95
Modification of the Cortical Impact Model To Produce Axonal Injury in the Rat Cerebral Cortex
Meaney, D. F., Ross, D. T., Winkelstein, B. A., Brasko, J., GOLDSTEIN, D., Bilston, L. E., Thibault, L. E., & Gennarelli, T. A. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.599 · Cited by 87
The role of oxygen radicals in the pathobiology of traumatic brain injury.
Povlishock, J. T., & Kontos, H. A. (1992) · PubMed · Cited by 85
Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis
Rosenstein, J. M., Krum, J. M., Sternberger, L. A., Pulley, M., & Sternberger, N. H. (1992) · Developmental Brain Research · doi:10.1016/0165-3806(92)90138-m · Cited by 79
Vascular disorder in Alzheimer’s disease: role in pathogenesis of dementia and therapeutic targets
Zloković, B. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00150-3 · Cited by 73
Alford, M. F., Masliah, E., Hansen, L. A., & Terry, R. D. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.2.8288869 · Cited by 66
Combined scopolamine and morphine treatment of traumatic brain injury in the rat
Lyeth, B. G., Liu, S., & Hamm, R. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)90614-s · Cited by 47
Sequestration of serum response factor in the hippocampus impairs long‐term spatial memory
Dash, P. K., Orsi, S. A., & Moore, A. N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.03016.x · Cited by 46
Self-citationRedell, J. B., Moore, A. N., & Dash, P. K. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800304 · Cited by 24
Self-citationDevelopment of Regional Cerebral Oedema After Lateral Fluid-Percussion Brain Injury in the Rat
McIntosh, T. K., Soares, H. D., Thomas, M., & Cloherty, K. (1990) · Springer eBooks · doi:10.1007/978-3-7091-9115-6_89 · Cited by 22
Cited by
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova-Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,027
Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury
Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.74 · Cited by 897
Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Calabrese, E. J., & Mattson, M. P. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3074 · Cited by 796
Stress-activated cap’n’collar transcription factors in aging and human disease
Sykiotis, G. P., & Bohmann, D. (2010) · Science Signaling · doi:10.1126/scisignal.3112re3 · Cited by 776
Small Molecule Modulators of Keap1‐ Nrf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
Magesh, S., Chen, Y., & Hu, L. (2012) · Medicinal Research Reviews · doi:10.1002/med.21257 · Cited by 760
Metadata
- Authors
- Zhao, J., Moore, A. N., Redell, J. B., & Dash, P. K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-09-19
- Volume
- 27
- Issue
- 38
- Pages
- 10240-10248
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2105455720
- Cited by
- 274
- References
- 39
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.